Antiandrogenic pharmacotherapy of sexual offenders and home leave steps in the forensic psychiatric hospital Berlin;Antiandrogene therapie und lockerungen bei sexualstraftätern im maßregelvollzug Berlin

Psychiatrische Praxis

Volumn 36, Issue 5, 2009, Pages 232-237

  Briken, Peer ^a   Welzel, Kathrin ^a   Habermann, Niels ^a   Hill, Andreas ^a   Berner, Wolfgang ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cyproterone acetate; LHRH agonist; Paraphilia; Sexual offenders

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST; CYPROTERONE ACETATE; GONADORELIN;

ADULT; AGED; ANTIANDROGEN THERAPY; ARTICLE; BONE PAIN; CRIMINAL LAW; DRY SKIN; FATIGUE; FORENSIC PSYCHIATRY; GERMANY; HEADACHE; HOME; HOT FLUSH; HUMAN; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; NAUSEA; RAPE; RECIDIVISM; RETROSPECTIVE STUDY; SCROTAL PAIN; SEXUAL CRIME; SEXUAL DEVIATION; SIDE EFFECT; VICTIM; VOMITING; WEIGHT GAIN; ADOLESCENT; DRUG POTENTIATION; DRUG UTILIZATION; HOSPITAL DISCHARGE; LEGAL ASPECT; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; STATISTICS; TREATMENT OUTCOME; VIOLENCE;

ADOLESCENT; ADULT; AGED; ANDROGEN ANTAGONISTS; BERLIN; COMMITMENT OF MENTALLY ILL; CYPROTERONE ACETATE; DRUG UTILIZATION; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; MIDDLE AGED; PARAPHILIAS; PATIENT DISCHARGE; RAPE; RECURRENCE; RETROSPECTIVE STUDIES; SEX OFFENSES; TREATMENT OUTCOME; VIOLENCE; YOUNG ADULT;

EID: 70350077748     PISSN: 03034259     EISSN: 14390876     Source Type: Journal    
DOI: 10.1055/s-0028-1090221     Document Type: Article

References (29)

1. Nedopil N. Behandlung psychisch Kranker erschwert. Dtsch Ärztebl 2006; 103: 2116-2118
2. Seifert D. Gefährlichkeitsprognosen: Eine empirische Untersuchung über Patienten des psychiatrischen Maßregelvollzugs. Darmstadt: Steinkopff, 2007
3. Dünkel F. Reformen des Sexualstrafrechts und Entwicklungen der Sexualdelinquenz in Deutschland. In: Schläfke D, Häßler F, Fegert JM. Sexualstraftaten - Forensische Begutachtung, Diagnostik und Therapie. Stuttgart: Schattauer, 2005: 1-31
4. Czerny JP, Briken P, Berner W. Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics. Eur Psychiatry 2002; 17: 104-106 (Pubitemid 34467873)
5. Briken P, Hill A, Berner W. Medikamentöse Therapie für Sexualstraftäter. In: Berner W, Briken P, Hill A. Sexualstraftäter behandeln. Köln: Deutscher Ärzteverlag, 2007: 133-147
6. Hill A, Briken P, Kraus C et al. Differential pharmacological treatment of paraphilias and sex offenders. Int J Offender Ther Comp Criminol 2003; 47: 407-421 (Pubitemid 36935026)
7. Briken P, Kafka MP. Pharmacological treatments for paraphilic patients and sexual offenders. Curr Opin Psychiatry 2007; 20: 609-613 (Pubitemid 47549121)
8. Berner W, Briken P. Paraphilia, sexual preference disorders. Diagnosis, etiology, epidemiology, treatment and prevention. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 33-43
9. Sammet K. Mehr Freiheit wagen? Cyproteronacetat, Sexualstraftäter und das "Gesetz über die freiwillige Kastration und andere Behandlungsmethoden" 1960-1975. Medizinhist J 2005; 40: 51-78
10. Eher R, Gnoth A, Birklbauer A et al. Antiandrogene Medikation zur Senkung der Rückfälligkeit von Sexualstraftätern: ein kritischer Überblick. Recht & Psychiatrie 2007; 25: 103-111 (Pubitemid 47407490)
11. Briken P, Berner W, Noldus J et al. Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate. Nervenarzt 2000; 71: 380-385 (Pubitemid 30326862)
12. Briken P, Nika E, Berner W. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists. J Sex Marital Ther 2001; 27: 45-55 (Pubitemid 32094966)
13. Briken P. Pharmacotherapy of paraphilias with luteinizing hormone-releasing hormone agonists. Arch Gen Psychiatry 2002; 59: 469-470 (Pubitemid 32094966)
14. Briken P, Hill A, Berner W. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review. J Clin Psychiatry 2003; 64: 890-897 (Pubitemid 37022754)
15. Briken P, Hill A, Berner W. A relapse in pedophilic sex offending and subsequent suicide attempt during luteinizing hormone-releasing hormone treatment. J Clin Psychiatry 2004; 65: 1429
16. Hopf HC, Philipowich G. Behandlung mit noch nicht zugelassenen Medikamenten - Zwischen Hoffen und Haften. Dtsch Ärztebl 2008; 105: 552-554
17. Nedopil N, Grassl P. Das Forensisch-Psychiatrische Dokumentations-system (FPDS). Forensia 1988; 9: 139-147
18. Hanson RK, Thornton D. Static 99: Improving actuarial risk assessments for sex offenders. Otawa: Department of the Solicitor General of Canada; 1999.
19. Deutsche Fassung: Rettenberger M, Eher R (2006) Actuarial Assessment of Sex Offender Recidivism Risk: A Validation of the German version of the Static-99. Sexual Offender Treatment, 2006; 3; http://www.sexual-offender- treatment.org/index.php?id= 51&type=123
20. Ressler RK, Burgess AW, Douglas JE. Sexual Homicide: Patterns and Motives. New York: The Free Press, 1988
21. Hill A, Ujeyl M, Habermann N et al. Schuldfähigkeit bei sexuellen Tötungsdelikten. Fortschr Neurol Psych 2008; 76: 343-353
22. Koller M. Triebdämpfende Medikation zwischen Rückfallprophylaxe und Körperverletzung. Recht & Psychiatrie 2008; 26: 187-199
23. Rösler A, Witztum E. Treatment of men with paraphilia with a long-acting analogue of gonadotropine-releasing hormone. N Engl J Med 1998; 338: 416-422 (Pubitemid 28135668)
24. Bradford JMW. The treatment of sexual deviation using a pharmacological approach. J Sex Res 2000; 37: 248-257
25. Bradford JMW. The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behavior. Can J Psychiatry 2001; 37: 248-257
26. Krueger RB, Kaplan MS. Depot-leuprolide acetate for treatment of paraphilias. A report of twelve cases. Arch Sex Behav 2001; 30: 409-422
27. Reilly DR, Delva NJ, Hudson RW. Protocols of the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia. Can J Psychiatry 2000; 45: 559-563
28. Berner W, Hill A, Briken P et al. DGPPN Leitlinien Störungen der Sexualpräferenz. Darmstadt: Steinkopff, 2007
29. Endrass J, Rossegger A, Noll T et al. Therapy effectiveness with violent and sex offenders. Psychiat Prax 2008; 35: 8-14 (Pubitemid 351183132)